Kodiak Sciences Inc. (KOD)
Largest Insider Buys in Sector
KOD Stock Price History Chart
KOD Stock Performance
About Kodiak Sciences Inc.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Insider Activity of Kodiak Sciences Inc.
Over the last 12 months, insiders at Kodiak Sciences Inc. have bought $0 and sold $12,453 worth of Kodiak Sciences Inc. stock.
On average, over the past 5 years, insiders at Kodiak Sciences Inc. have bought $187.7M and sold $7.31M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 13,155 shares for transaction amount of $104,363 was made by BAKER FELIX () on 2022‑06‑02.
List of Insider Buy and Sell Transactions, Kodiak Sciences Inc.
| 2024-06-17 | Sale | BORGESON JOHN A. | See Remarks | 2,874 0.0053% | $2.75 | $7,904 | -2.97% | |
| 2024-06-12 | Sale | BORGESON JOHN A. | See Remarks | 1,558 0.0031% | $2.92 | $4,549 | -4.48% | |
| 2023-06-16 | Sale | BORGESON JOHN A. | See Remarks | 2,749 0.0054% | $9.23 | $25,373 | -64.83% | |
| 2023-06-16 | Sale | EHRLICH JASON | See Remarks | 2,258 0.0044% | $9.23 | $20,841 | -64.83% | |
| 2023-06-14 | Sale | BORGESON JOHN A. | See Remarks | 1,448 0.0029% | $9.42 | $13,640 | -64.89% | |
| 2023-06-14 | Sale | EHRLICH JASON | See Remarks | 1,132 0.0023% | $9.42 | $10,663 | -64.89% | |
| 2022-06-15 | Sale | BORGESON JOHN A. | See Remarks | 2,798 0.0053% | $7.02 | $19,642 | +3.65% | |
| 2022-06-15 | Sale | EHRLICH JASON | See Remarks | 2,282 0.0043% | $7.02 | $16,020 | +3.65% | |
| 2022-06-02 | BAKER FELIX | 13,155 0.0255% | $7.93 | $104,363 | -6.75% | |||
| 2022-05-25 | BAKER FELIX | 116 0.0002% | $6.75 | $784 | +10.48% | |||
| 2022-05-16 | BAKER FELIX | 8,118 0.0163% | $5.99 | $48,599 | +29.47% | |||
| 2022-02-25 | Sale | PERLROTH VICTOR | Chairman and CEO | 340,000 0.6641% | $8.99 | $3.06M | -12.81% | |
| 2022-02-24 | Sale | PERLROTH VICTOR | Chairman and CEO | 1M 1.9233% | $9.20 | $9.2M | -16.03% | |
| 2022-02-17 | BAKER BROS. ADVISORS LP | 300,000 0.5801% | $54.56 | $16.37M | -85.71% | |||
| 2022-02-16 | BAKER BROS. ADVISORS LP | 95,165 0.1782% | $54.12 | $5.15M | -86.03% | |||
| 2022-02-15 | BAKER BROS. ADVISORS LP | 5,800 0.0107% | $54.16 | $314,099 | -86.22% | |||
| 2022-01-31 | BAKER BROS. ADVISORS LP | 30,148 0.0563% | $57.22 | $1.73M | -86.58% | |||
| 2022-01-28 | BAKER BROS. ADVISORS LP | 55,258 0.0977% | $50.42 | $2.79M | -85.58% | |||
| 2022-01-27 | BAKER BROS. ADVISORS LP | 262,259 0.5015% | $51.76 | $13.57M | -84.81% | |||
| 2022-01-25 | BAKER BROS. ADVISORS LP | 5,500 0.0104% | $58.90 | $323,934 | -86.82% |
Insider Historical Profitability
| BORGESON JOHN A. | See Remarks | 182164 0.3394% | $2.29 | 0 | 8 | |
| BAKER FELIX | 15617369 29.7631% | $2.29 | 3 | 0 | +11.07% | |
| BAKER BROS. ADVISORS LP | 14734965 28.0814% | $2.29 | 41 | 0 | +62.31% | |
| PERLROTH VICTOR | Chairman and CEO | 2168038 4.1318% | $2.29 | 0 | 2 | |
| Liang Hong | SVP, Discovery Medicine | 130166 0.2481% | $2.29 | 0 | 3 | |
| EHRLICH JASON | See Remarks | 61924 0.118% | $2.29 | 0 | 32 | |
| PROFUSEK ROBERT | director | 10000 0.0191% | $2.29 | 1 | 0 | <0.0001% |
| Levy Richard S | director | 1000 0.0019% | $2.29 | 1 | 0 | +40.96% |
Institutional Investor Ownership
| Baker Bros Advisors LP | $91.05M | 32.95 | 17.31M | 0% | +$0 | 1.14 | |
| BlackRock | $20.3M | 7.35 | 3.86M | -4.32% | -$916,297.24 | <0.0001 | |
| Acadian Asset Management | $9.06M | 3.28 | 1.72M | -9.72% | -$974,901.07 | 0.03 | |
| The Vanguard Group | $8.7M | 3.15 | 1.65M | +0.67% | +$57,744.28 | <0.0001 | |
| Ecor1 Capital Llc | $8.49M | 3.07 | 1.61M | New | +$8.49M | 0.22 | |
| Silverarc Capital Management Llc | $6.52M | 2.36 | 1.24M | +23.88% | +$1.26M | 1.92 | |
| D. E. Shaw & Co. | $5.49M | 1.99 | 1.04M | -13.59% | -$864,338.98 | 0.01 | |
| ICONIQ Capital | $5.35M | 1.94 | 1.02M | 0% | +$0 | 0.09 | |
| Newtyn Management | $5.26M | 1.9 | 1M | -43.54% | -$4.06M | 1.14 | |
| Morgan Stanley | $4.78M | 1.73 | 908,851 | +294.13% | +$3.57M | <0.0001 | |
| Tcg Crossover Management Llc | $4.73M | 1.71 | 899,999 | +235.89% | +$3.32M | 0.01 | |
| State Street | $3.93M | 1.42 | 747,495 | +3.76% | +$142,335.61 | <0.0001 | |
| Geode Capital Management | $3.8M | 1.38 | 722,961 | +2.08% | +$77,415.04 | <0.0001 | |
| Invesco | $3.71M | 1.34 | 705,317 | +790.61% | +$3.29M | <0.01 | |
| Board Of Trustees Of The Leland Stanford Junior University | $3.64M | 1.32 | 691,767 | 0% | +$0 | 0.32 | |
| Hudson Bay Capital Management LP | $3.29M | 1.19 | 625,000 | New | +$3.29M | 0.03 | |
| Renaissance Technologies | $3.06M | 1.11 | 581,400 | -6.27% | -$204,597.77 | 0.01 | |
| Jacobs Levy Equity Management | $2.76M | 1 | 525,650 | -27.36% | -$1.04M | 0.01 | |
| Ikarian Capital LLC | $2.51M | 0.91 | 476,586 | +15.43% | +$335,088.25 | 0.72 | |
| Dimensional Fund Advisors | $2.24M | 0.81 | 426,705 | -2.36% | -$54,188.54 | <0.01 | |
| Bruce Co Inc | $2.22M | 0.81 | 423,000 | -10.57% | -$263,000.00 | 0.93 | |
| Goldman Sachs | $1.85M | 0.67 | 352,480 | -10.43% | -$215,870.42 | <0.0001 | |
| Two Sigma Advisers LP | $1.7M | 0.62 | 323,600 | +5.79% | +$93,102.00 | <0.01 | |
| Avidity Partners Management Lp | $1.58M | 0.57 | 300,000 | New | +$1.58M | 0.06 | |
| Bank of America | $1.51M | 0.55 | 287,014 | +313.34% | +$1.14M | <0.0001 | |
| Charles Schwab | $1.38M | 0.5 | 263,276 | +9.24% | +$117,192.82 | <0.0001 | |
| Northern Trust | $1.35M | 0.49 | 256,919 | +0.97% | +$12,971.16 | <0.0001 | |
| Millennium Management LLC | $1.15M | 0.42 | 218,839 | -58.91% | -$1.65M | <0.01 | |
| Atom Investors Lp | $902,064.00 | 0.33 | 171,495 | +63.32% | +$349,727.00 | 0.11 | |
| Fidelity Investments | $810,613.00 | 0.29 | 154,109 | +1.38% | +$11,014.43 | <0.0001 | |
| Wellington Management Company | $772,373.00 | 0.28 | 146,839 | New | +$772,373.00 | <0.0001 | |
| Nuveen | $765,062.00 | 0.28 | 145,449 | 0% | +$0 | <0.0001 | |
| Los Angeles Capital Management LLC | $697,103.00 | 0.25 | 132,529 | -14% | -$113,458.27 | <0.01 | |
| Acuitas Investments, LLC | $693,284.00 | 0.25 | 131,803 | -43.7% | -$538,040.31 | 0.36 | |
| Boothbay Fund Management LLC | $680,844.00 | 0.25 | 129,438 | +37.47% | +$185,588.61 | 0.02 | |
| BNY Mellon | $631,700.00 | 0.23 | 120,095 | -6.41% | -$43,226.70 | <0.0001 | |
| Marshall Wace | $618,024.00 | 0.22 | 117,495 | New | +$618,024.00 | <0.01 | |
| Bridgeway Capital Management | $600,692.00 | 0.22 | 114,200 | 0% | +$0 | 0.01 | |
| SEI Investments Company | $595,211.00 | 0.22 | 113,158 | New | +$595,211.00 | <0.01 | |
| Cubist Systematic Strategies | $592,686.00 | 0.21 | 112,678 | +250.86% | +$423,761.18 | 0.01 | |
| Ria Advisory Group Llc | $488,817.00 | 0.18 | 92,931 | New | +$488,817.00 | 0.2 | |
| Jane Street Capital | $391,576.00 | 0.14 | 74,444 | -38.69% | -$247,088.85 | <0.0001 | |
| Two Sigma | $364,818.00 | 0.13 | 69,357 | -79.18% | -$1.39M | <0.01 | |
| AllianceBernstein | $347,318.00 | 0.13 | 66,030 | 0% | +$0 | <0.0001 | |
| Deutsche Bank | $318,677.00 | 0.12 | 60,585 | -16.34% | -$62,231.04 | <0.0001 | |
| Barclays | $312,000.00 | 0.11 | 59,418 | -41.9% | -$224,965.77 | <0.0001 | |
| RhumbLine Advisers | $294,153.00 | 0.11 | 55,925 | +1.55% | +$4,502.37 | <0.0001 | |
| Connor Clark & Lunn Investment Management Ltd | $249,997.00 | 0.09 | 47,528 | New | +$249,997.00 | <0.01 | |
| Massachusetts Financial Services Co Ma | $243,338.00 | 0.09 | 46,262 | New | +$243,338.00 | <0.0001 | |
| American Century Investments | $241,187.00 | 0.09 | 45,853 | +53.69% | +$84,254.76 | <0.0001 |